Double life: How GRK2 and β-arrestin signaling participate in diseases

Cell Signal. 2022 Jun:94:110333. doi: 10.1016/j.cellsig.2022.110333. Epub 2022 Apr 14.

Abstract

G-protein coupled receptor (GPCR) kinases (GRKs) and β-arrestins play key roles in GPCR and non-GPCR cellular responses. In fact, GRKs and arrestins are involved in a plethora of pathways vital for physiological maintenance of inter- and intracellular communication. Here we review decades of research literature spanning from the discovery, identification of key structural elements, and findings supporting the diverse roles of these proteins in GPCR-mediated pathways. We then describe how GRK2 and β-arrestins partake in non-GPCR signaling and briefly summarize their involvement in various pathologies. We conclude by presenting gaps in knowledge and our prospective on the promising pharmacological potential in targeting these proteins and/or downstream signaling. Future research is warranted and paramount for untangling these novel and promising roles for GRK2 and arrestins in metabolism and disease progression.

Keywords: GPCR regulation; GRK; arrestins; cancer; diseases; heart failure; metabolism; pain.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrestins* / metabolism
  • G-Protein-Coupled Receptor Kinases* / metabolism
  • Phosphorylation
  • Receptors, G-Protein-Coupled / metabolism
  • Signal Transduction / physiology
  • beta-Arrestin 1 / metabolism
  • beta-Arrestin 2 / metabolism
  • beta-Arrestins / metabolism

Substances

  • Arrestins
  • Receptors, G-Protein-Coupled
  • beta-Arrestin 1
  • beta-Arrestin 2
  • beta-Arrestins
  • G-Protein-Coupled Receptor Kinases